Form 4: Prothena Corp Director, Shane Cooke, Acquires 15,000 Stock Options

Director Shane Cooke acquired 15,000 stock options in Prothena Corp on May 15, 2024.

Summary

• On May 15, 2024, Shane Cooke, a director of Prothena Corp Public Ltd Co, acquired 15,000 stock options.
• The exercise price of these options is $22.39.
• The options vest on the earlier of the first anniversary of the grant date or the date of the annual general meeting in 2025, assuming continuous service as a director.
• The options expire on May 15, 2034.

Sentiment

Score: 6

Explanation: Neutral sentiment. This is a routine disclosure of stock option grants to a director. It doesn't inherently indicate positive or negative sentiment, but rather reflects standard corporate governance practices.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting of the options is tied to continued service as a director, suggesting an expectation of ongoing involvement with the company.

Industry Context

This is a standard Form 4 filing, reflecting insider activity. Monitoring insider transactions can provide insights into management's perspective on the company's prospects relative to others in the biotechnology industry.

Comparison to Industry Standards

• Stock option grants are a common form of compensation for directors in publicly traded companies, particularly in the biotechnology sector.
• The vesting schedule and exercise price are typical for such grants, aligning the director's interests with those of shareholders.
• Comparing the size of this grant to those of directors at similar-sized biotech companies (e.g., Alnylam Pharmaceuticals, Biogen) would provide context on its relative significance.

Stakeholder Impact

• The acquisition of stock options by a director aligns their interests with those of shareholders, potentially encouraging decisions that increase shareholder value.

Key Dates